Skip to main content

and
  1. No Access

    Article

    Integrating pharmacogenetics into gemcitabine dosing—time for a change?

    A number of biomarkers that predict clinical outcome in response to gemcitabine treatment have been identified. These markers could be used in the clinic to personalize treatment, thereby improving efficacy an...

    Joseph Ciccolini, Cédric Mercier, Laetitia Dahan in Nature Reviews Clinical Oncology (2011)

  2. Article

    Open Access

    Mixed Streptococcus pneumoniae and Streptococcus pyogenes meningitis in an immunocompromised adult patient: a case report

    Community-acquired meningitis is a monomicrobial infection caused by either viruses or bacteria in the vast majority of patients. We report here one exceptional case of a patient with mixed bacterial meningiti...

    Clémence Demerle, Vadim Ivanov, Cédric Mercier in Journal of Medical Case Reports (2015)